Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease

JACC Cardiovasc Imaging. 2017 May;10(5):594-597. doi: 10.1016/j.jcmg.2016.02.029. Epub 2016 Jun 29.

¹ Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Nuclear Medicine, European University of Brittany, EA3878 GETBO, CHRU Brest, Brest, France.
² Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York; British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: marc.dweck@ed.ac.uk.
³ Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
⁴ Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁵ Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Keywords: (18)F-fluorodeoxyglucose; PET/MR; late gadolinium enhancement.

Publication types